Y Intercept Hong Kong Ltd boosted its holdings in shares of Anterix Inc. (NASDAQ:ATEX – Free Report) by 14.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,742 shares of the company’s stock after acquiring an additional 1,112 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Anterix were worth $329,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ATEX. Bank of New York Mellon Corp lifted its stake in Anterix by 8.0% in the second quarter. Bank of New York Mellon Corp now owns 50,605 shares of the company’s stock valued at $2,003,000 after buying an additional 3,752 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in shares of Anterix in the 2nd quarter valued at about $28,000. Jupiter Asset Management Ltd. bought a new stake in shares of Anterix in the second quarter valued at about $200,000. Renaissance Technologies LLC bought a new stake in shares of Anterix in the second quarter valued at about $1,334,000. Finally, Gabelli Funds LLC grew its holdings in shares of Anterix by 4.7% during the second quarter. Gabelli Funds LLC now owns 140,422 shares of the company’s stock worth $5,559,000 after buying an additional 6,322 shares in the last quarter. 87.67% of the stock is owned by institutional investors and hedge funds.
Anterix Stock Performance
Anterix stock opened at $31.90 on Wednesday. The stock has a 50-day simple moving average of $33.45 and a 200 day simple moving average of $35.71. The stock has a market capitalization of $593.91 million, a P/E ratio of -16.28 and a beta of 0.85. Anterix Inc. has a 52 week low of $29.12 and a 52 week high of $42.41.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Anterix
Insiders Place Their Bets
In related news, Director Mark Fleischhauer purchased 3,500 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The stock was acquired at an average cost of $34.19 per share, for a total transaction of $119,665.00. Following the completion of the purchase, the director now owns 3,500 shares in the company, valued at approximately $119,665. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Leslie B. Daniels bought 2,000 shares of Anterix stock in a transaction dated Wednesday, November 20th. The shares were bought at an average cost of $32.75 per share, for a total transaction of $65,500.00. Following the completion of the acquisition, the director now owns 2,000 shares in the company, valued at $65,500. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Company insiders own 45.61% of the company’s stock.
Anterix Profile
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Featured Stories
- Five stocks we like better than Anterix
- High Dividend REITs: Are They an Ideal Way to Diversify?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- When to Sell a Stock for Profit or Loss
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Salesforce’s Clear Path to $400 and Beyond
Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEX – Free Report).
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.